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ABSTRACT 
 
The misfolding and self-assembly of amyloid-β (Aβ) into oligomers and fibres is fundamental to 
Alzheimer’s disease pathology. Alzheimer’s disease is a multifaceted disease. One factor that is 
thought to have a significant role in disease aetiology is Zn
2+
 homeostasis, which is disrupted in 
the brains of Alzheimer’s disease sufferers, and has been shown to modulate Alzheimer’s 
symptoms in animal models. Here we investigate how the kinetics of Aβ fibre growth are 
affected at a range of Zn
2+
 concentrations, and use transmission electron microscopy to 
characterise the aggregate assemblies formed. We demonstrate that for Aβ(1-40), and Aβ(1-42), as 
little as 0.01 mole equivalents of Zn
2+
 (100 nM) is sufficient to greatly perturb the formation of 
amyloid fibres irreversibly. Instead, Aβ(1-40) assembles into short rod-like structures that pack 
tightly together into ordered stacks, whereas Aβ(1-42) forms short crooked assemblies that knit 
together to form a mesh of disordered tangles. Our data suggests that a small number of Zn
2+
 
ions are able to influence a great many Aβ molecules through the rapid exchange of Zn2+ 
between Aβ peptides. Surprisingly, although Cu2+ binds to Aβ ten-thousand times tighter than 
Zn
2+
, the effect of Zn
2+
 on Aβ assembly dominates in Cu2+/Zn2+ mixtures, suggesting trace levels 
of Zn
2+ must have a profound effect on extracellular Aβ accumulation.  Trace Zn2+ levels 
profoundly influences A assembly even at concentrations weaker than its affinity for A These 
observations indicate inhibitors of fibre assembly do not necessarily have to be at high 
concentration and affinity to have a profound impact. 
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INTRODUCTION 
 It is estimated that there are currently 30 million people worldwide suffering with Alzheimer’s 
disease, with incidence expected to double in the next 20 years [1]. The pathology of Alzheimer’s disease 
is characterised by the misfolding of a small peptide, amyloid-β, and its subsequent aggregation into 
oligomers, fibres and plaques [2]. Amyloid-β (Aβ) is cleaved from amyloid-precursor protein (APP), 
largely forming the two alloforms Aβ(1-40) and Aβ(1-42), of which Aβ(1-42) more readily aggregates to form 
fibres and synaptotoxic oligomers [3, 4].  
 The aggregation of Aβ into fibres and oligomers is generally accepted to underlie Alzheimer’s 
disease neurotoxicity. However, it is not clear what promotes the initial misfolding of Aβ in sporadic 
Alzheimer’s disease, or what promotes aggregation of the neurotoxic oligomers and fibres over benign 
amorphous aggregates [5, 6]. One possibility is that aggregation is influenced through elevated Zn
2+ 
[7], 
for which levels
 
in the neuropil are increased 2-fold in patients with Alzheimer’s disease [8].  
 Zn
2+
 is an important intracellular signalling molecule that is thought to be crucial for synaptic 
plasticity, learning, and memory [9-11]. In the brain, large reserves of free Zn
2+
 are found to be stored in 
the presynaptic vesicles of glutamatergic neurons, transported there by Zinc transporter-3 (ZnT3) [12-15]. 
These stores of Zn
2+ 
exit the vesicles with glutamate following neuronal depolarisation, and are reported 
to bind and regulate the function of a range of neurotransmitter receptors, including N-methyl-D-aspartate 
(NMDA)-type glutamate receptors [16]. A general consensus has been reached that the affinity of Zn
2+
 for 
Aβ at pH 7.4 is within the range 1 – 20 μM [17-19]; though this is a relatively moderate affinity, the high 
levels of Zn
2+
 at the synapse especially during depolarisation, when Zn
2+ 
 is reported to reach 
concentrations of up to 100 – 300 µM [20-22], implies synaptic Aβ would be expected to bind 
endogenous Zn
2+  
[23]. 
 There is much evidence to support Zn
2+
 homeostasis being associated with Alzheimer’s disease 
pathology. It has been found that a Cu
2+
/Zn
2+
 chelator, PBT2, decreases soluble Aβ levels and improves 
cognition in Alzheimer’s disease transgenic mice [24], and in another study, it has been found that for two 
transgenic mouse models of Alzheimer’s disease (Tg2576 and TgCRND8), a Zn2+ enriched diet is 
associated with potentiated Alzheimer’s-like spatial memory impairment, as well as a reduction in Aβ 
plaque deposition, potentially increasing soluble toxic Aβ levels [25]. Furthermore, in drosophila models 
of Alzheimer’s disease, tight control of copper and zinc availability reduces disease phenotypes [26]. 
Conversely, Zn
2+
 supplementation for 3 x TG-AD transgenic mice actually attenuated disease pathology 
[27]. In support of this mice depleted of synaptic Zn
2+
 through a ZnT3 knockout mutation present age-
dependent memory impairments similar to those observed in Alzheimer’s disease models [28]; this is 
particularly significant as the authors found that ZnT3 levels decline in humans with aging, particularly 
those with Alzheimer’s disease [29]. Thus it currently unclear from animal models of AD whether Zn2+ is 
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protective or harmful, as both increases and decreases are seen to both accentuate and potentiate disease 
phenotypes. 
 It is thought that Zn
2+
 influences Alzheimer’s disease pathology through direct binding to the Aβ 
peptide.  Typically, Zn
2+
 forms tetrahedral complexes, although 5 and 6 coordinate complexes are also 
possible. Three histidine residues (His6, His13, His14) within Aβ along with carboxylate coordination 
from Glu11 or Asp1 (possibly with the N-terminal amino group) have been identified as the Zn
2+
 
coordinating ligands [17, 18, 30, 31]. The complex is in rapid exchange (on NMR timescales), and these 
ligands may well be in a dynamic exchange [18, 30]. Furthermore, the histidine residues that complex 
Zn
2+ 
may come from different Aβ peptides, generating cross-linked Aβ [30, 32].  
 Metal ions binding to Aβ may alter the kinetics of on-pathway amyloid fibre formation, or 
alternatively, promote formation of off-pathway aggregates [33]. Initially, it was thought that Zn
2+
 
promoted formation of off-pathway, amorphous aggregates [34-39]; however, it has also been reported 
that Zn
2+ can cause Aβ to form annular protofibrils [40, 41]. Zn2+ is thought to induce Aβ(1-40) to rapidly 
form disc shaped oligomers that are highly toxic to primary cell culture, but may then  further aggregate 
to form non-toxic assemblies [42]. Conversely, it was recently reported that Zn
2+
 can slow Aβ(1-40) fibre 
growth, without affecting the number of fibres ultimately formed [43]. Consequently, though many 
studies agree that Zn
2+
 has a profound effect on Aβ misfolding, which aggregate species develop from the 
Aβ-Zn2+ interaction is still not fully resolved.  
 A great amount of research has highlighted the importance of controlling Zn
2+
 levels in the brains 
of Alzheimer’s disease sufferers and those at risk of developing the disease, while emphasising that both 
an excess of Zn
2+
 and Zn
2+ 
deficiency may be pathogenic [24-29, 42, 44]. Thus, it is of importance to 
understand how Aβ is influenced by Zn2+ at a full range of concentrations, and whether glutamate may 
affect the Aβ-Zn2+ interaction, particularly as Zn2+ is released at the synapse with glutamate [12-15]. In 
this study, we have used thioflavin-T (ThT) fluorescence, and transmission electron microscopy (TEM) to 
clarify the influence of Zn
2+
 on Aβ self-association, for both Aβ(1-42) and Aβ(1-40) alloforms, at a range of 
physiologically relevant conditions, including extremely low substoichiometric levels of Zn
2+
.  
 The interaction of a second divalent metal ion, Cu
2+, with Aβ has also generated a lot of attention 
[45]. Cu
2+ 
is also  released at the synapse during depolarisation [46], and has a 50 pM affinity for Aβ [47]. 
We have previously shown that while substoichiometric Cu
2+
 accelerates Aβ(1-40) fibre formation [48], 
Cu
2+
 stabilises protofibrillar/oligomeric assemblies of Aβ(1-42), and can even rapidly convert Aβ(1-42) fibres 
to protofibrillar/oligomeric assemblies [49]. We have investigated the effect of a range of Cu
2+
 and Zn
2+
 
mixtures on Aβ assemblies, as both are present extracellularly at the synapse, and share histidine 
coordinating ligands.  Cu
2+
 is not displaced by the presence of Zn
2+
 but the coordination geometry is 
influenced by the presence of Zn
2+
 [50, 51].  
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 Here we demonstrate that trace levels of Zn
2+
 (0.01 mole equivalents, 100 nM) profoundly 
influences the misfolding pathways of both Aβ(1-42) and Aβ(1-40). Our data suggests this occurs through a 
rapid exchange mechanism, that enables Zn
2+ 
to exert more influence over Aβ assembly than Cu2+ in 
Zn
2+
/Cu
2+
 mixtures, despite the latter having a much higher (10
11
 versus 10
5
) affinity for Aβ. 
 
RESULTS 
 Zn
2+ 
and Aβ(1-42) Assembly – The well-established amyloid-binding ThT fluorescence assay was 
used to examine the fibre formation kinetics of Aβ(1-42) at a range of Zn
2+
 concentrations, with TEM being 
used to examine the species of aggregates formed. The fibre growth of Aβ progresses through a 
nucleation-dependent pathway, for which formation of an oligomeric nucleus precedes elongation of Aβ 
into mature fibrils [52, 53]. This classic pattern of fibre formation is observed for Aβ(1-42) in the absence of 
Zn
2+
, while at 2 mole equivalents, Zn
2+
 is found to abolish ThT binding amyloid assembly (Fig. 1A), as 
has been observed by others [34-37, 40-42, 44, 45, 48]. We then wanted to determine whether much 
lower levels of Zn
2+
 are also capable of influencing Aβ(1-42) misfolding. We investigated the effect of 
substoichiometric levels of Zn
2+
 on Aβ(1-42) fibre growth, and found that as little as 0.01 mole equivalents 
of Zn
2+
 is sufficient to greatly perturb Aβ(1-42) fibre growth (Fig. 1B), even though at any one time ~ 99 % 
of Aβ molecules will not be bound to Zn2+.  
 In vivo, following depolarisation, glutamate is released with large reserves of Zn
2+
 present, we were 
interested in whether glutamate may modulate the effect of Zn
2+
 upon Aβ(1-42) self-association. Our ThT 
data shows that in the presence of two-fold as much glutamate as Zn
2+
, 0.01 mole equivalents of Zn
2+
 
(100 nM)
 
is still sufficient to greatly impede the rate of Aβ(1-42) fibre growth and reduce the total amount 
of ThT fluorescent assemblies by 75% (Fig. 1C).  It is important to note that the impact on ThT 
fluorescence intensity is not a direct quenching effect of Zn
2+
, as addition of Zn
2+
 to preformed fibres has 
no effect on the intensity of the ThT fluorescence signal (data shown later in Fig. 6a). 
 We characterised the morphology of the Aβ(1-42) assemblies formed using TEM, figure 2. Our 
images show that in the absence of Zn
2+
, Aβ(1-42) predominantly formed amyloid fibres, with a typical 
straight unbranched morphology of 10 – 20 nm thickness (depending on the number of filaments stacked 
together), and many microns in length. However, as little as 0.05 equivalents of Zn
2+
 visibly influences 
the heterogeneous population of aggregates that develop (Fig. 2b-c), with Aβ(1-42) generally forming very 
disjointed crooked fibril-like assemblies, 10 nm thick and 50 – 200 nm long, that are non-ThT binding. 
These short fibrous aggregates self-associate to form large disorderly tangles that are not observed in the 
absence of Zn
2+
. These tangles were 100 – 1000 nm wide, densely stained, and had no repeating structure. 
At 2 equivalents of Zn
2+
 large disorderly tangles, resembling those observed for 0.05 equivalents of Zn
2+
, 
predominated, (Fig. 2c-d). Our TEM images also demonstrate that the influence of Zn
2+
 on Aβ(1-42) 
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aggregation is not markedly altered by the presence of glutamate (Fig. 2E-H). Thus, our data show that 
both substoichiometric and suprastoichiometric levels of Zn
2+
 promote Aβ(1-42) to form disorderly tangles, 
rather than growth of mature amyloid fibrils, and that this is relevant in vivo, as we found glutamate does 
not prevent this affect. These observations were made consistently, over numerous Zn
2+
-Aβ(1-42) 
preparations and TEM grids.  
  
 Zn
2+
 and Aβ(1-40) Assembly – It has previously been observed that the effect of Cu
2+
 on Aβ(1-42) and 
Aβ(1-40) assembly differs substantially [49]. Consequently, we used ThT fluorescence to investigate how 
Aβ(1-40) amyloid fibre growth is influenced by Zn
2+
, at a range of Zn
2+
 concentrations (Fig. 3). As for Aβ(1-
42), as little as 0.01 equivalents of Zn
2+
 was able to inhibit growth of Aβ(1-40) fibres, with the total amount 
of ThT binding fibres being consistently reduced by more than a half, but not abolished.  We also 
demonstrate that these low levels of Zn
2+
 were able to perturb Aβ(1-40) fibre growth even in the presence of 
glutamate (Fig. 3B).   
 Using TEM we characterised what species of Aβ(1-40) aggregates formed in the presence of varying 
levels of Zn
2+
. We found that there are apparent differences between Aβ(1-40) and Aβ(1-42) assembly in the 
presence of low levels of Zn
2+
, but not for suprastoichiometric levels
 
(Fig. 4). The images show that in the 
absence of Zn
2+, Aβ(1-40) forms typical straight unbranched amyloid fibres, 10 – 20 nm thick and many 
microns in length. The presence of 0.05 equivalents of Zn
2+
 greatly reduces the number of mature amyloid 
fibres that form, and, unlike for Aβ(1-42), promotes the formation of short rod-like fibres, which are 10 – 20 
nm thick, 50 – 200 nm long, and pack closely together, to form stacks 50 – 300 nm thick (Fig. 4B). These 
stacks were observed at greater number for 0.2 equivalents of Zn
2+
 (Fig. 4C). For 2 equivalents of Zn
2+
, 
we observe a similar effect as for Aβ(1-42), as large disordered tangles predominate. These tangles were 
found to be 100 – 1000 nm wide, densely stained, and to have no repeating structure (Fig. 4D).  
 Notably, we found that the presence of glutamate did not influence the effect of Zn
2+
 upon Aβ(1-40) 
misfolding (Fig. 4E-H). Thus the differences in behaviour between Aβ(1-40) and Aβ(1-42) at low levels of 
Zn
2+
 could potentially be relevant in vivo. These observations were made consistently, over numerous 
Zn
2+
-Aβ(1-42) preparations and TEM grids.     
 A time course of TEM images of Aβ(1-40) with Zn
2+
 at  0.0, 0.4 and 2.0 mole equivalents was 
also generated.  After 2 hours incubation, at pH 7.4, oligomeric structure (ca 5 nm in diameter) were just 
detectable. At 3 hours the difference between oligomers observed with and without Zn
2+
 were not marked 
however by 4 hours, differences were apparent between 0.4 equivalents Zn
2+
 loaded and apo Aβ(1-40), 
Figure 5.  For the Zn
2+
 loaded Aβ(1-40), by 4 hours, short irregular assemblies are apparent, which are not 
observed in the Zn
2+
 free samples which instead form circular shaped oligomers, Figure 5.  TEM images 
of Aβ(1-40) with 2.0 mole equivalents Zn
2+
 shows similar kinetics and morphology of assembly to 0.4 
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equivalent Zn
2+
; specifically short irregular assemblies are apparent after 4 hours incubation (data not 
shown). 
 
 Recently a study reported the effect of Zn
2+ 
on Aβ(1-40) fibre formation, using ThT to monitor fibre 
formation kinetics [43]. Interestingly, an increase in lag-times were observed with addition of Zn
2+
, but no 
reduction in ThT intensity was reported [43]. We wondered if this conflict with our own data, shown in 
figure 3, might be due to the use of phosphate buffer, which will compete for Zn
2+
 and form poorly 
soluble ZnPO4.  Repeating this experiment with phosphate buffer; we found there was some reduction in 
ThT signal but that this was less marked than in the absence of phosphate buffer (data not shown).  Even 
with phosphate buffer there was still a marked extension in lag-times in the presence of Zn
2+ 
as recently 
reported [43]. Our TEM images of those preparations indicate short rod-shaped fibres of Zn-Aβ(1-40) were 
generated in the presence of substoichiometric Zn
2+
 and phosphate buffer, with a similar appearance to 
those shown in figure 4, despite the presence of phosphate buffer. 
  
 Adding and Removing Zn
2+
 from Aβ Assemblies at Equilibrium – We investigated the effect of 
adding Zn
2+ 
to mature preformed Aβ(1-40) fibres. Using a ThT assay (Fig. 6A), we found that after adding 
0.4 mole equivalents of Zn
2+
 to the preformed mature amyloid fibres, ThT fluorescence stayed constant 
following a further 100 hours of incubation, suggesting that Zn
2+
 does not readily disassemble fully 
formed amyloid fibres. This data also confirms that Zn
2+ 
does not directly quench ThT fluorescence in the 
presence of amyloid fibre.  This was corroborated by TEM data, figure 6B, which showed that the mature 
Aβ(1-40) fibres to which Zn
2+
 was added retained a typical amyloid fibre structure, and did not adopt the 
structural features of short rod-like assemblies characteristic of freshly solubilized Aβ(1-40) incubated with 
Zn
2+
.  
 In addition to this, we wanted to see whether aggregates formed in the presence of Zn
2+
 would 
persist in the absence of Zn
2+
. For this investigation, we added EDTA (a strong Zn
2+
 chelator) to both 
Aβ(1-42) and Aβ(1-40) samples which had previously been incubated with Zn
2+
 (Fig. 7). Our data suggests 
that removal of Zn
2+
 from Aβ does not enable resumption of amyloid fibre formation, as ThT signal did 
not increase following EDTA addition. Our TEM confirmed that the aggregate species formed when 
freshly solubilized Aβ is incubated with Zn2+ persist once Zn2+ is removed with EDTA. This data suggests 
that Zn
2+
 promotes formation of aggregates that are off-pathway to amyloid fibre formation. Interestingly, 
even the short rod structures (formed with Aβ(1-40) + Zn
2+
), whose gross morphology is reminiscent of 
amyloid fibres, do not seed the formation of ThT binding fibres once Zn
2+
 is removed by EDTA (Fig. 
7B).  
 We wanted to further characterize the Zn
2+
 induced A assemblies. CD spectra (Fig. 8), indicate 
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the -sheet content, as assessed by the minima at 217 nm, is comparable to that generated for both apo 
Aβ(1-40) and Aβ(1-42) fibres, even though the ThT florescence signal for these assemblies is reduced by 
between half and three-quarters respectively. Regardless of Zn
2+
 inducing off-pathway Aβ aggregates, 
Zn
2+
 induced assemblies have high β-sheet content similar to Aβ incubated in the absence of Zn2+ (Fig. 8).  
Freshly solubilized Aβ has a negative CD signal at 198 nm typical of an intrinsically disordered peptide, 
with little CD signal at 217 nm.  
  
 
 Aβ Seeding with Zn2+ - It is notable that the influence of Zn2+ on Aβ formation does not occur in a 
stoichiometric manner; our data here has shown that even as little as 0.01 equivalents of Zn
2+
 substantially 
perturbs fibre formation. Thus, it is evident that a single Zn
2+
 ion can influence the assembly of many Aβ 
molecules, promoting alternative assemblies rather than the strongly fluorescent ThT binding amyloid 
fibres. This could occur through two potential mechanisms: a seeding mechanism, in which Zn
2+
 binding 
causes an Aβ nucleus to adopt a conformation capable of recruiting monomeric Aβ to form the non-
typical assemblies that we have observed, or a dynamic exchange model, in which the rapid exchange of 
Zn
2+
 between Aβ molecules allows a greater number of Aβ molecules to be influenced by low levels of 
Zn
2+
 than one may otherwise expect.  
 To investigate which mechanism is more likely, we carried out a seeding experiment (Fig. 9) 
analogous to the protein misfolding cyclic amplification experiments used for studying prion proteins 
[54]. In our experiment freshly solubilized Aβ was incubated with 0.4 mole equivalents of Zn2+ for a 
week, which was then used to seed a subsequent experiment, consisting of 10 % seed and 90 % freshly 
solubilized Aβ, which in turn was incubated for a week and used to seed a further experiment. 
 This was repeated until there was only 0.0004 mole equivalents of Zn
2+
 present in the final 
experiment. We found that ThT fluorescent signal generally increased between experiments, and by the 
final experiment the ThT fluorescence had approximately returned to that observed for freshly solubilized 
Aβ incubated without Zn2+ (Fig. 9A). Supporting the ThT data, our TEM images demonstrate that Aβ 
aggregate species formed in later seeding experiments closely resembles the Aβ(1-40) and A(1-42) 
fibres produced in the absence of Zn
2+
, Figure 9B-E.  
 As the concentration of Zn
2+
 was reduced in sequential seeding experiments, Zn
2+
 induced 
aggregate species became less evident; this suggests that the dynamic exchange mechanism more 
accurately models how a small number of Zn
2+
 ions influence a large number of Aβ molecules. If a 
seeding mechanism was taking place, the Zn
2+
 induced aggregate species formed in the initial 
experiments would be able to promote formation of similar aggregates in sequential experiments, 
regardless of reductions in Zn
2+
 levels.  
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The Effect of Cu
2+
 and Zn
2+
 Mixtures on Aβ Misfolding - The presence of Cu2+ has also been 
shown to influence fibre formation [48, 49] [33, 55]. Additionally, both divalent metal ions are released at 
the synapse and are thought to chelate to Aβ via its histidine residues [18, 30, 47]. Consequently, it is 
striking that not only does Zn
2+
 influence Aβ fibre formation at much lower equivalents than Cu2+, but 
that it does so in a markedly different way. This is most evident for Aβ(1-40), for which substoichiometric 
Cu
2+
 accelerates fibre formation [48, 49], while Zn
2+
 prevents fibre formation. As we were interested in 
whether either of these metal ions could modulate or mask the other’s effect, we used ThT fluorescence to 
follow Aβ(1-40) fibre growth in the presence of a variety of Cu
2+
:Zn
2+
 mixtures. As is apparent in figure 
10A, even when there was only a quarter as much Zn
2+
 as there was Cu
2+
, the effect on fibre aggregation 
of Zn
2+
 predominated. In particular, ThT signal is reduced four-fold, and there is no acceleration in fibre 
growth. As the concentration of Zn
2+ 
(100 – 300 μM) is generally thought to be higher than that of Cu2+                 
(15 – 250 μM) at the synapse [46, 56], our data suggests that in vivo the effect of Zn2+ may exert the 
greater influence on Aβ misfolding. This is supported by our TEM data, figure 10B; here the assembly 
outcome for mixtures of Zn
2+
 and Cu
2+
 (0.2 and 0.4 equivalents respectively) is dominated by the 
presence of Zn
2+. Aβ(1-40) assembled into short fibril-like rods, that packed together in bundles, as is 
observed when Aβ(1-40) is incubated with Zn
2+
 in the absence of Cu
2+
.  
 
DISCUSSION      
 Trace Zn
2+
 and Aβ Fibre Assembly – We have demonstrated that supra-stoichiometric levels of 
Zn
2+
 completely abolish Aβ fibre growth, as has previously been reported [34-38, 44, 48], and induces 
Aβ(1-40) and Aβ(1-42) to form disordered tangled aggregates. We have shown here that as little as 0.01 mole 
equivalents of Zn
2+
 (100 nM) also significantly influenced the misfolding pathway of both Aβ(1-40) and 
Aβ(1-42). It is notable that the marked influence of such very low amounts of Zn
2+
 on Aβ assembly is even 
more remarkable when we consider the affinity of Zn
2+
 for Aβ. The effect is observable with 100 nM of 
Zn
2+
, but Zn
2+
 affinity for Aβ is much weaker, at 10 μM [17-19]. Only a fraction, 0.005 mole equivalents 
of Zn
2+
, will be bound to Aβ at any one time, at an A concentration of 10 M.  We were surprised that a 
single Zn
2+
 ion can influence the aggregation of so many Aβ molecules, as each Zn2+ ion can only be 
bound to one or two Aβ molecules, at one time.  
 There are a number of potential mechanisms through which trace levels of Zn
2+
 could influence 
large numbers of Aβ molecules. Although Zn2+ cross-linking Aβ may contribute, it is insufficient to 
explain the very low substoichiometric amount of Zn
2+
 that effects fibre formation.  Alternatively, the 
length of fibres may be restricted by Zn
2+
 bound Aβ peptide, capping the end of fibres and limiting fibril 
length, or introducing sharp kinks into the fibre (Fig. 11). However, the stoichiometric ratio of Zn
2+
 to Aβ 
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does not correlate to fibre length, Zn
2+
 promoted aggregates have a similar appearance, irrespective of 
Zn
2+
 stoichiometry; 0.05 or 2 mole equivalent. A more likely explanation is the rapid exchange of Zn
2+
 
between Aβ peptides. For fibrillogenesis, Aβ monomers need to adopt a specific conformation to bind to 
a growing fibre [57-59]; however, Zn
2+
 may rapidly exchange between Aβ peptides, altering the 
population of conformations typically available to them, and restricting the population of the necessary 
fibre forming conformation.  This metal ion induced entropic expansion of conformational space, for 
disordered proteins, has recently been described [60]. A fourth possibility would be that Zn
2+
 binding 
promotes the formation of a unique seed, which may direct downstream Aβ aggregation through a 
template mechanism, however our seeding experiment (Fig. 9) shows this to be unlikely. Instead our data 
supports a dynamic exchange of Zn
2+
 between Aβ peptides as the most credible explanation; this is 
consistent with 
1
H NMR data that suggests a rapid exchange of Zn
2+
 between Aβ peptides on a milli- to 
micro-second time-scale [18, 30].  
Our data shows that trace levels of Zn
2+
 influence Aβ(1-40) and Aβ(1-42) misfolding in distinct ways; 
with Aβ(1-40), Zn
2+
 induced formation of short rod-like structures that stack together in bundled structures, 
whereas with Aβ(1-42), typically Zn
2+
 promotes the formation of short crooked disordered fibrous 
assemblies that knit together.  The dissimilarity in how substoichiometric levels of Zn
2+
 influence Aβ(1-40) 
and Aβ(1-42) isoforms may arise from differences in the fibril assembly pathways and fibre structure [61-
63]. 
Our time-course TEM images indicate Zn
2+
 generates distinctive assembles of A(1-40) early in the 
assembly pathway, at 4 hours.  Interestingly, although assemblies generated with Zn
2+
-Aβ(1-40) have a 
markedly reduced ThT fluorescence, studies using soild-state NMR suggest the basic cross-β structure is 
maintained [64], and we have demonstrated here a large proportion of -sheet content to be retained. 
 Several experiments were carried out to contextualise our results to an in vivo environment. In 
vivo, Zn
2+
 is released at the synapse bound to glutamate [12-15], so it was important to determine whether 
glutamate modulated the effect of Zn
2+
 upon Aβ. We found that glutamate had no influence, indicating 
glutamate’s affinity (Kd1 = 600 μM at pH 7.4) [65] for Zn
2+
 is not sufficient to prevent Zn
2+
 influencing 
Aβ assembly. Additionally, as levels of Zn2+ fluctuate in the brain with depolarisation [20, 46], it was of 
interest to observe the effect of Zn
2+
 upon preformed mature fibrils and also the reversibility of Zn
2+
 
induced aggregation. We found that Zn
2+
 did not influence mature Aβ fibrils, nor did removal of Zn2+ 
enable aggregates formed with Zn
2+
 to revert and form fibres. This suggests the misfolding pathway of 
Zn
2+
 induced assemblies is distinct from that of amyloid fibril growth.  In contrast, protofibril assemblies 
of Aβ(1-42) generated by the presence of Cu
2+ 
will rapidly seed fibre formation upon Cu
2+
 chelation [49]. 
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 Contrasting and Dominating Influence of Zn
2+
 over Cu
2+
 in Fibre Assembly – Another divalent 
metal ion that is thought to be important in Alzheimer’s disease pathology is Cu2+ [45, 48, 49, 66-68]. 
Interestingly, although the two divalent metal ions share a number of the same coordination ligands [17, 
18, 30, 47, 50, 51, 69], there are marked differences in the influence of Zn
2+
 and Cu
2+
 on Aβ misfolding, 
as outlined in Table 1. In particular, substoichiometric Cu
2+
 accelerates Aβ(1-40) fibre growth [48, 49], 
while substoichiometric Zn
2+
 shows a reduced total fibre growth for both alloforms. A further difference 
between Zn
2+
 and Cu
2+
 is the amount that is required to disrupt Aβ misfolding, with Zn2+ having a much 
greater influence at lower levels than Cu
2+
. In particular, the influence of Cu
2+
 on Aβ assemblies is only 
apparent at stoichiometries of greater than 0.25 [48, 49], 25 times greater than the 0.01 levels of Zn
2+
 
required to disrupt fibre growth. The differences in the effects of Cu
2+
 and Zn
2+
 are presumably in part 
due to differences in the metal binding exchange rate with Aβ.  
 As Cu
2+
 and Zn
2+ 
are elevated in Alzheimer’s disease, and both metal ions are released at the 
synapse, but differ in their relationship to Aβ, we sought to determine the net effect when Aβ(1-40) was 
incubated with mixtures of Zn
2+
 and Cu
2+
. We were surprised to find that when both ions were present, 
Cu
2+ 
had little influence upon Aβ(1-40) fibre growth. Although the affinity of Cu
2+
 for Aβ is much higher 
than Zn
2+ 
by more than 5 orders of magnitude, (50 pM and 10 μM respectively) [18, 47]. Zn2+ has the 
ability to rapidly exchange (ms-µs) between Aβ molecules [18, 30] and influence a large number of Aβ 
peptide conformations, this results in Zn
2+
 dominating Aβ assembly in mixtures of substoichiometric Cu2+ 
and Zn
2+
. In contrast, the off rate of Cu
2+
 binding to Aβ will be relatively slow with its tight pM affinity.  
 This highlights that Zn
2+
 may be important in Alzheimer’s disease pathology, not only through 
directly influencing Aβ misfolding, but through attenuating the effect of other factors, such as Cu2+. For 
instance, in vivo, Cu
2+
 levels may become elevated, but have no effect due to a dominant influence of 
Zn
2+
, or alternatively, Cu
2+
 levels may remain stable, but changes in Zn
2+
 levels result in an associated 
change in the relationship between Cu
2+
 and Aβ. The fact that substoichiometric levels of Zn2+ influenced 
Aβ misfolding differently to suprastoichiometric levels, and that Zn2+ may influence the effect of Cu2+, 
provides an explanation as to why Zn
2+
 supplementation has been found to both attenuate and potentiate 
Alzheimer’s like symptoms in animal studies [24, 25, 27, 29], as not only is Aβ misfolding extremely 
sensitive to Zn
2+, but also to the ratio of Aβ and Zn2+ as well as its interplay with Cu2+. It has recently been 
shown that physiologically relevant N-terminally truncated forms of A have a femto-molar affinity for 
Cu
2+
 [70],  it remains to be established what impact Zn
2+
 might have on these very tightly bound Cu
2+
 
complexes.  
  
 To conclude, Zn
2+
 and Cu
2+
 homeostasis has been implicated in Alzheimer’s disease pathology, 
through a number of animal studies [24, 25, 29, 66-68]. Additionally, Zn
2+
 is prevalent at the 
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glutamatergic neurons, often described as zincergic neurons [71, 72]. This study highlights the many 
variables to be considered in delineating the role of Zn
2+
 and Cu
2+
 in Alzheimer’s disease pathology, as 
effect will be dependent on Aβ isoform, metal ion-Aβ stoichiometry, and relative metal ion 
concentrations. This complexity is underscored by finding that shifts of 0.01 equivalents of Zn
2+
 (100 nM) 
bound to glutamate are sufficient to change the misfolding landscape of Aβ. However, a complex system 
also provides many routes for intervention, in this particular case, chelation/supplementation of Zn
2+
/Cu
2+
 
could provide such a route. A high-throughput screening in a yeast model of Aβ toxicity found that a 
Zn
2+
/Cu
2+ chelator, clioquinol, ameliorated Aβ toxicity [73]. Clioquinol has also been found to inhibit Aβ 
deposition and ameliorate symptoms, in a mouse model of AD [74], further emphasising the potential 
importance of regulating metal homeostasis in Alzheimer’s disease. 
              The observation that Zn
2+
 can profoundly impact the assemblies of Aβ at concentrations two 
orders of magnitude weaker than its affinity for A highlights the possibility that small molecules can 
profoundly influence A assembly even when simple considerations of low affinity and low 
stoichiometry might suggest that their likely impact on Aβ assembly would be minor. It is clear the 
binding exchange-rate of potential therapeutic amyloid modulators may be very important in influencing 
assembly, rather than simply their concentration and affinity for A. 
 
MATERIALS AND METHODS  
 Aβ production and solubilisation – Lyophilised Aβ(1-40) and Aβ(1-42) was purchased commercially 
from Cambridge Research Biochemicals and Zinser. Peptides were synthesised using solid phase F-moc 
chemistry, and HPLC indicated a single peak at the expected molecular mass. Characterisation of the 
peptides was carried out using 
1
H NMR, which confirmed that Met
35
 was un-oxidised. Lyophilised Aβ(1-
40) and Aβ(1-42) were solubilised at a concentration of 0.7 mg/ml in water at pH 10.5, using NaOH, and 
then left at 5 
o
C for 12 hours, as described by [75]. It is clear that solubilised preparations of Aβ have low 
levels of fibre nucleating assemblies as at pH 7.4 solubilised Aβ preparations typically have a clear lag-
phase. Furthermore, negative stain TEM images at pH 7.4 show no detectable oligomer assemblies 
directly after solubilisation. Furthermore a single elusion peak is observed in size exclusion 
chromatograph. Aβ concentration was determined using the Tyrosine absorbance at 280 nm, ε280 = 1280 
M
-1 
cm
-1
.  
  
 Fibre growth assay – The kinetics of amyloid formation were monitored using binding of 
Thioflavin T (ThT) to amyloid fibres, which induces ThT to fluoresce at 487 nm; this signal is typically 
directly proportional to the amount of amyloid fibrils present [76]. BMG-Galaxy and BMG-Omega 
FLUOstar fluorescence 96-well plate readers were used for the measuring of ThT fluorescence. 
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Fluorescence readings were typically taken every 30 mins, following 30 seconds of mild agitation. 
Fluorescence excitation and emission detection were at 440 nm and 490 nm respectively. Well-plates 
were sealed with clear polyolefin film (STARLAB) to stop evaporation.  
     Fibre growth kinetics are sensitive to a number of factors, including pH, concentration, agitation, ionic 
strength and temperature; consequently, measures were taken to reduce variance in these parameters, and 
the identical Aβ stock solution was split when making direct kinetic comparisons. Fibre growth 
experiments were incubated at 30 
0
C and in 30 mM HEPEs buffer (due to its low affinity for Zn
2+
 and 
Cu
2+
 ions) and in 10 or 160 mM NaCl (Sigma-Aldrich; <20 ppm of trace metals).  The pH, a critical 
factor in rate of fibre growth, was adjusted to pH 7.4 with small additions of 10 mM NaOH and HCl; 
variation between samples was measured to be 0.05 pH units or less. Typically one molar equivalents of 
ThT was added using a fresh 2 mM stock. Cu
2+
 and Zn
2+
 stock solutions were 10 mM CuCl2.2H2O and 10 
mM ZnCl2 (Sigma-Aldrich; <20 ppm of trace metals). Contaminate levels of Zn
2+ 
(<50 nM) and Cu
2+ 
(<500 nM) are shown not to have a detectable impact on fibre growth kinetics or fibre morphology for the 
types of in vitro experiment described [48, 49].  Thus any Zn
2+
 and Cu
2+
 contaminant from the buffer will 
not impact these studies. Ethylenediaminetetraacetic acid (EDTA) stock was 1 mM (UHQ (ultra-high 
quality) water (10
-18
 Ω-1 cm-1 resistivity) was used for all experiments.  The final volume in each well was 
200 μl, with 96 wells per plate. 
  
 Growth curve analysis – Conversion of essentially monomeric Aβ to Aβ fibres follows a 
characteristic growth curve, consisting of first a lag-phase (nucleation; dominated by both primary and 
secondary nucleation, and fragmentation) and then a growth-phase (elongation; dominated by monomer 
addition to growing fibres).  
 A growth curve can be fitted to the data, to obtain a number of empirical parameters, using the 
following equation [77]: 
 
𝑌 =  (𝜐𝑖 + 𝑚𝑖𝑥) +  
(𝜐𝑓 + 𝑚𝑓𝑥 )
1 + 𝑒𝑥𝑝
−((𝑥−𝑥0 ) 𝜏⁄ )
    (eq 1)         
       
Y represents fluorescent intensity, and x represents time. Initial fluorescence intensity is represented by 
i, f represents the final fluorescence intensity, and x0 is the time at which half maximal fluorescence is 
reached (t50). The apparent fibre growth rate (kapp), is obtained by 1/ and the lag-time (tlag) by x-2This 
equation allows for a slope in the initial and final parts of the growth curve, (i + mix), (f + mfx), rather 
than forcing these to be horizontal. Data was processed using KaleidaGraph 4.0 graphing and data 
analysis software. 
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 Transmission electron microscopy (TEM) – 5 l samples were added to flow-discharged carbon-
coated 300-mesh grids using the droplet method, with UHQ H2O washes before and after addition of 
negative-stain. Phosophotungstic acid (2 % w/v), adjusted to pH 7.4, was used to negatively stain the 
sample. Selected images are representative of multiple images (~50) that were taken over multiple fields 
and grids. Control TEM images of buffer show no detectable staining. Images were recorded using a 
JEOL JEM-1230 electron microscope operated at 80 keV, and the Olympus iTEM software package.  
  
 Circular Dichroism (CD) – Spectra were recorded at 25 oC, between 195 and 260 nm, on an 
Applied Photophysics Chirascan instrument. We sampled points every 2 nm, and carried out 3 repeat 
scans per spectrum, using a 0.1 cm path-length cuvette. A baseline spectrum was subtracted from each 
spectrum, and a 3 nm smoothing window applied, after which the data was zeroed at 260 nm. CD 
ellipticity values (θ millidegrees) were converted to molar CD, Δε (M-1 cm-1), using the following 
equation: 
  
𝛥𝜀 =  𝜃/(33,000. 𝑐. 𝑙)    (eq 2)         
 
 In the above equation c represents molar concentration (M) and l represents path-length (cm). Data was 
processed using Photophysics Chirascan Viewer, Microsoft Excel, and Kaleidagraph 4.0. 
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FIGURE 1. Aβ(1-42) fibre growth with Zn2+. A. Aβ(1-42) fibre growth, monitored by Thioflavin T 
fluorescence, with no Zn
2+ 
(red) and 2 equivalents of Zn
2+
 (blue). B. Aβ(1-42) fibre growth with no Zn
2+
 
(red), 0.01 equivalents of Zn
2+
 (orange), and 0.05 equivalents (green). C. Aβ(1-42) fibre growth with 
glutamate and Zn
2+
. No Zn
2+
 (red); 0.01 equivalents of Zn
2+
 (orange); 0.05 equivalents of Zn
2+ 
(green), 
and 2 equivalents of Zn
2+
 (blue). Ratio of Zn
2+
:glutamate; 1:2. As little as 0.01 equivalents of Zn
2+
 
strongly inhibited ThT fluorescent fibre formation. Fibre growth was carried out at pH 7.4, with 10 μM 
Aβ(1-42), 30 mM HEPES, 160 mM NaCl and mild agitation, at 30 
o
C. (typically N = 6 traces). 
 
FIGURE 2. TEM Images of Aβ(1-42) with Zn
2+ 
and glutamate. A-H. representative TEM images of Aβ(1-
42) samples incubated with: No Zn
2+
 (A); 0.05 equivalents of Zn
2+
 (B and C); 2.0 equivalents of Zn
2+
 (D); 
no Zn
2+
 (E); 0.05 equivalents of Zn
2+
 (F); 0.4 equivalents of Zn
2+ 
(G); and 2.0 equivalents of Zn
2+ 
(H). E – 
H  also have glutamate present; ratio Zn
2+
:glutamate is 1:2 . All samples were negatively stained with 
phosphotungstic acid. Scale bars are 250 nm.  
 
FIGURE 3. Aβ(1-40) fibre growth with Zn2+.   A. Aβ(1-40) fibre growth, monitored by Thioflavin T 
fluorescence, with no Zn
2+ 
(red), 0.05 equivalents of Zn
2+
  (orange), 0.2 equivalents of Zn
2+
 (green), 0.4 
equivalents of Zn
2+
 (blue) and 2 equivalents of Zn
2+
 with (purple).   B. Aβ(1-40) fibre growth with Zn
2+
 and 
glutamate, where the Zn
2+
:glutamate ratio is 1:2. No Zn
2+ 
(red), 0.01 equivalents of Zn
2+
 with (orange), 
0.05 equivalents of Zn
2+
 (green), and 0.4 equivalents of Zn
2+
 (blue). Fibre growth was carried out at pH 
7.4, with 10 μM Aβ(1-40), 30 mM HEPES, 10 mM NaCl and agitation, at 30 
o
C. (N = 4 – 6 traces). 
 
FIGURE 4. TEM Images of Aβ(1-40) with Zn
2+ 
and glutamate. A-H. Representative TEM images of 
Aβ(1-40) samples, incubated with no Zn
2+
 (A), 0.05 equivalents of Zn
2+
 (B), 0.2 equivalents of Zn
2+
(C), 2 
equivalents of Zn
2+ 
(D), 4 equivalents of glutamate no Zn
2+ 
(E), 0.05 equivalents of Zn
2+
 (F), 0.2 
equivalents of Zn
2+
 (G), and 0.4 equivalents of Zn
2+
 (H).   E-H as Zn
2+
:glutamate, ratio is 1:2.  All 
samples were stained with phosphotungstic acid. Scale bars are 250 nm.  
 
FIGURE 5: Influence of Zn
2+ on Aβ(1-40) assembly over time: Aβ(1-40)  fibres formed in the absence of 
Zn
2+
 (top row) and in the presence of 0.4 mole equivalents Zn
2+ 
(bottom row) monitored over time using 
TEM. Samples were incubated for 2 weeks with aliquots taken at different time points. Images are shown 
at 3 hrs, 4 hrs and 2 weeks. At four hours there are marked differences in the assemblies due to the 
presence of Zn
2+. Aβ(1-40) (10 μM) was grown at pH 7.4 in 30 mM HEPES buffer and 160 mM NaCl at 25 
°C with no agitation. 
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FIGURE 6. Zn
2+ added to mature Aβ(1-40) fibres. A. Aβ(1-40) fibre growth, monitored by Thioflavin T 
fluorescence, to which buffer (red) and 0.4 equivalents of Zn
2+
 (blue) was added at 250 hours. Fibre 
growth was carried out at pH 7.4, with 10 μM Aβ(1-42), 30 mM HEPES, 10 mM NaCl and agitation, at 
30 
o
C. (N = 3 Traces). B. Representative TEM image of  mature Aβ(1-40) fibres, which after fibre growth 
were incubated with 0.4 equivalents of Zn
2+ 
 for 100 hours. The addition of Zn
2+
 to mature fibres has no 
effect on content or appearance. Samples were stained with phosphotungstic acid. Scale bar is 250 nm.  
 
FIGURE 7. EDTA 
 added to Aβ fibres incubated with Zn
2+
. A. Aβ(1-40) fibre growth, monitored by 
Thioflavin T fluorescence, for samples with no Zn
2+
 (red),  0.05 equivalents of Zn
2 
(green), and 0.4 
equivalents of Zn
2+
 (blue), to which 50 µM EDTA was added at 250 hours (n = 3).  B. Representative 
TEM image of Aβ(1-40) incubated with 0.4 equivalents Zn
2+
, to which 50 μM EDTA was added after 250 
hours, and incubated for a further 100 hours.  C. ThT fluorescence for Aβ(1-42) with no Zn
2+
 (red),  1 
equivalents of Zn
2+
 (green), and 2 equivalents of Zn
2+
 (blue), to which 50 µM EDTA was added at 265 
hours (n = 6).  D. Representative TEM image of Aβ(1-42) incubated with 2 equivalents Zn
2+
, to which 50 
μM EDTA was added after, and incubated for a further 70 hours. fibre growth was carried out at pH 7.4, 
with 10 μM Aβ, 30 mM HEPES, 10 mM NaCl and agitation, at 30 oC. Samples were stained with 
phosphotungstic acid. Scale bar is 500 nm. Once Aβ(1-40) or Aβ(1-42) form Zn
2+
 induced aggregates EDTA 
has little effect.  
 
FIGURE 8. Circular dichroism spectra of Aβ incubated with Zn
2+
. A. Aβ(1-40) incubated with either no 
Zn
2+ 
(red) or 0.05 mole equivalents of Zn
2+ 
(blue). B. Aβ(1-42) incubated with either no Zn
2+ 
(red) or 0.05 
mole equivalents of Zn
2+ 
(blue). 20 μM Aβ samples were incubated with 5 mM HEPES, at pH 7.4, at 30 
o
C under agitated conditions for over 200 hours. Although Zn
2+
 profoundly effects the morphology of Aβ 
assemblies, apparent β-sheet content is retained. 
 
FIGURE 9. Aβ and Zn
2+
 cross-seeding. A, Maximal ThT fluorescence of Aβ(1-40) 
 
(grey) and Aβ(1-42) 
(black) with 0.4 equivalents of Zn
2+
, which after a week were used to seed monomeric Aβ (1st seeding), 
which in turn were also used to seed monomeric Aβ (2nd seeding), which again were used to seed 
monomeric Aβ (3rd seeding). Seeds were 10 % of final volume. Fluorescence is presented as a percentage 
of ThT fluorescence for mature Aβ(1-40) 
 
and Aβ(1-42) fibres grown in the absence of Zn
2+ 
 the dotted line. 
Fibre growth was carried out at pH 7.4, with 10 μM Aβ, 30 mM HEPES, 10 mM NaCl and agitation, at 
30 
o
C. B – E. Representative TEM images of Aβ(1-42) and Aβ(1-40) grown with 0.4 equivalents of Zn
2+
 (B,C); 
2
nd
 seeding for Aβ(1-42) and Aβ(1-40)  contains 0.004 equivalents of Zn
2+
 (D,E).  Samples were stained with 
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phosphotungstic acid. Scale bars are 500 nm. Zn
2+
 generated assemblies could not seed similar assemblies 
once Zn
2+
 was diluted. 
  
FIGURE 10. Aβ(1-40) fibre growth with mixtures of Cu
2+
 and Zn
2+
. 
 
A. Aβ(1-40) fibre growth, monitored 
by Thioflavin T fluorescence, with no metal ions (red), 0.4 equivalents of Cu
2+
 (blue), 0.4 equivalents of 
both Cu
2+
 and Zn
2+
 (green), 0.4 equivalents of Cu
2+
 and 0.2 equivalents of Zn
2+
(purple), and 0.4 
equivalents of Cu
2+
 and 0.1 equivalents of Zn
2+ 
(orange). Fibre growth was carried out at pH 7.4, with 10 
μM Aβ(1-40), 30 mM HEPES, 10 mM NaCl and agitation, at 30 
o
C, (N = 3 – 6 Traces).  B. Representative 
TEM image of Aβ(1-40)  incubated with 0.4 mole equivalents of Cu
2+
 and 0.2 equivalents of Zn
2+
. Samples 
were stained by phosphotungstic acid. Scale bar 200 nm. Assembly outcome is dominated by presence of 
Zn
2+
, with short rods and weak ThT signal observed, rather than long fibres.  
 
FIGURE 11. Schematic of Zn 
2+
 Induced Assemblies.  A. Binding of Zn
2+
 to Aβ peptide in rapid 
exchange prevents a large number of Aβ molecules from forming fibres. Alternatively a single Zn2+ ion 
may influence a great number of Aβ peptides through capping the ends of fibres, and inducing formation 
of bundles of crooked assemblies (B) or short rods (C).  Although scenario B and C are less probable as 
increasing ratios of Zn:Aβ do not affect the appearance of the cross-seeded assemblies. TEM Scale bars, 
200 nm. 
 
 
TABLE 1. Aβ aggregate species in the presence of metal ions. This table shows the predominant 
species of Aβ aggregate formed upon reaching equilibrium, after 200 hours, in the presence of Zn2+ and 
Cu
2+, at pH 7.4, with 10 μM Aβ, 30 mM HEPES, 10 mM NaCl and mild agitation, at 30 oC. 
 
